NVIV - InVivo Therapeutics Holdings Corp.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 514.83M
Enterprise Value 3-971.55k
Trailing P/E N/A
Forward P/E 1-1.75
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 60.07

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-42.24%
Return on Equity (ttm)-156.18%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -13.46M
Net Income Avi to Common (ttm)-25.56M
Diluted EPS (ttm)-21.639
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)19.71M
Total Cash Per Share (mrq)2.12
Total Debt (mrq)216k
Total Debt/Equity (mrq)1.17
Current Ratio (mrq)6.93
Book Value Per Share (mrq)-0.47

Cash Flow Statement

Operating Cash Flow (ttm)-13.43M
Levered Free Cash Flow (ttm)-4.42M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.37
52-Week Change 3-93.60%
S&P500 52-Week Change 35.56%
52 Week High 333.750
52 Week Low 31.630
50-Day Moving Average 32.045
200-Day Moving Average 33.370

Share Statistics

Avg Vol (3 month) 3168.45k
Avg Vol (10 day) 396.51k
Shares Outstanding 57.76M
Float 9.29M
% Held by Insiders 10.18%
% Held by Institutions 19.08%
Shares Short (Oct 31, 2018) 4420.96k
Short Ratio (Oct 31, 2018) 41.3
Short % of Float (Oct 31, 2018) 426.95%
Short % of Shares Outstanding (Oct 31, 2018) 45.42%
Shares Short (prior month Sep 28, 2018) 4227.77k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/25
Last Split Date 3Apr 17, 2018